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In an age when we can sequence an
entiregenomewithinaday,weexpecttobe
able to gather and access accurate infor-
mation at a pace. After all, you didn’t wait
for this issue of PLoSMedicine to arrive inthe
post ortrudge downto the librarytoreadit;
you accessed it instantly via the internet.
Patients and clinicians also expect technol-
ogy to provide similar speed when it comes
to diagnosing infectious disease. Recent
research and analysis published in PLoS
Medicinerevealsathemeofrapiddiagnostics
and raises the question of whether provid-
ing an answer quickly is enough to produce
meaningful health outcomes.
For patients suffering from any infec-
tious disease, diagnosis should pave the
way to treatment. Reducing the lag time
between testing and diagnosis has obvious
advantages for the patient by ensuring
timely receipt of care, and this should in
turn benefit others by reducing the
probability of transmission. In December
last year the World Health Organization
(WHO) endorsed the use of a new
automated PCR-based test for tuberculosis
(TB), known as Xpert, which can rapidly
confirm infection and detect resistance to
rifampicin [1,2]. Many countries currently
rely on sputum smear microscopy and
culture to diagnose TB, which can take
weeks to provide results. The new test
takes under two hours to provide a
diagnosis, fueling high hopes that it will
transform TB diagnosis and therefore
treatment. However, there is an additional
cost associated with Xpert—each test
cartridge currently costs approximately
US$17 [3]—and despite being sold at
reduced rates in countries where TB is
endemic, question marks remain about
whether it will be a cost-effective option in
low- and middle-income settings.
Since speed and convenience come at a
cost, is that cost worthwhile? In a recent
PLoS Medicine essay, David Dowdy and
colleagues highlighted the challenges of
determining the cost-effectiveness of rapid
TB diagnostics, including the danger of
draining resources from other TB-specific
interventions and the need to take into
account the cost of treating false-positive
diagnoses [4]. WHO’s recent policy rec-
ommendation against the use of rapid
commercial serological tests for active TB
serves as a stark reminder of the need to
evaluate diagnostics fully [5]. The kits may
be both rapid and convenient, but as a
meta-analysis by Karen Steingart and
colleagues in PLoS Medicine has shown, they
fail in their primary purpose since they are
neither accurate nor consistent enough to
replace sputum smear microscopy as a test
for TB [6]. The consequences of this failure
have been substantial because the kits are
widely used in countries with the highest
TB burden, and it has been suggested that
the cost of testing and treating false-
positives may rival the annual budget of
India’s entire TB control program ($65
million) [7]. While the accuracy of Xpert is
not in doubt, substantial challenges remain
before the scale-up of this rapid test delivers
on its promise.
Speedier and more convenient still are
diagnostics that can be packaged into
reliable self-test kits, which may improve
testing uptake for diseases that carry a
significant social stigma, such as HIV.
Anthony Choko and colleagues report in
PLoS Medicine that self-testing for HIV can
be used in the field to produce accurate
results and may indeed improve testing
uptake [8]. In their study, just over 90% of
people interviewed agreed to test for HIV
using an oral self-test kit, with most
expressing a preference for self-testing for
future HIV tests. Particularly encouraging
is the high proportion of men reporting a
preference to be self-tested in this way, as
they are a demographic who in this setting
have a poor record for HIV testing.
However, an important question re-
mains unanswered by this research: is
there any advantage to a 20 minute test if
a self-diagnosed person remains isolated
from counseling or care? This is a question
raised in an illuminating Perspective
article by Rochelle Walensky and Ingrid
Bassett that accompanies the new study
[9]. They argue that knowing one’s HIV
status is undoubtedly a critical first step,
but that we must ensure that increased
speed and convenience of testing doesn’t
break the chain of care. If we can’t ensure
that rapid testing is translated into care we
are in danger of going nowhere fast.
We are fortunate to live in a time when
technology enables us to rapidly gather
and process information; the ability to do
so is transforming health care. However,
these papers serve as a timely reminder
that rapidly detecting the cause of an
illness is not in itself enough to significantly
change health outcomes.
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